Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland; Wolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, London, UK.
Schistosomiasis Consortium for Operational Research and Evaluation, University of Georgia, Athens, GA, USA.
Lancet Glob Health. 2019 Aug;7(8):e1118-e1129. doi: 10.1016/S2214-109X(19)30189-5. Epub 2019 Jun 26.
Elimination of schistosomiasis as a public health problem and interruption of transmission in selected areas are targets set by WHO for 2025. Our aim was to assess biannual mass drug administration (MDA) applied alone or with complementary snail control or behaviour change interventions for the reduction of Schistosoma haematobium prevalence and infection intensity in children from Zanzibar and to compare the effect between the clusters.
In a 5-year repeated cross-sectional cluster-randomised trial, 90 shehias (small administrative regions; clusters) in Zanzibar eligible owing to available natural open freshwater bodies and public primary schools were randomly allocated (ratio 1:1:1) to receive one of three interventions: biannual MDA with praziquantel alone (arm 1) or in combination with snail control (arm 2), or behaviour change activities (arm 3). Neither participants nor field or laboratory personnel were blinded to the intervention arms. From 2012 to 2017, annually, a single urine sample was collected from approximately 100 children aged 9-12 years in the main public primary school of each shehia. The primary outcome was S haematobium infection prevalence and intensity in 9-12-year-old children after 5 years of follow-up. This study is completed and was registered with the ISRCTN, number 48837681.
The trial was done from Nov 1, 2011, through to Dec 31, 2017 and recruitment took place from Nov 2, 2011, until May 17, 2017. At baseline we enrolled 8278 participants, of whom 2899 (35%) were randomly allocated to arm 1, 2741 (33%) to arm 2, and 2638 (32%) to arm 3. 120 (4·2%) of 2853 in arm 1, 209 (7·8%) of 2688 in arm 2, and 167 (6·4%) of 2613 in arm 3 had S haematobium infections at baseline. Heavy infections (≥50 eggs per 10 mL of urine) were found in 126 (1·6%) of 8073 children at baseline. At the 5-year endline survey, 46 (1·4%) of 3184 in arm 1, 56 (1·7%) of 3217 (odds ratio [OR] 1·2 [95% CI 0·6-2·7] vs arm 1) in arm 2, and 58 (1·9%) of 3080 (1·3 [0·6-2·9]) in arm 3 had S haematobium infections. Heavy infections were detected in 33 (0·3%) of 9462 children.
Biannual MDA substantially reduced the S haematobium prevalence and infection intensity but was insufficient to interrupt transmission. Although snail control or behaviour change activities did not significantly boost the effect of MDA in our study, they might enhance interruption of transmission when tailored to focal endemicity and applied for a longer period. It is now necessary to focus on reducing prevalence in remaining hotspot areas and to introduce new methods of surveillance and public health response so that the important gains can be maintained and advanced.
University of Georgia Research Foundation Inc and Bill & Melinda Gates Foundation.
世界卫生组织设定了 2025 年消除血吸虫病这一公共卫生问题并在选定地区阻断传播的目标。我们的目的是评估在桑给巴尔岛,每两年进行一次大规模药物治疗(MDA)单独应用或与补充性灭螺或行为改变干预措施相结合,用于降低儿童中血吸虫病的流行率和感染强度,并比较组间的效果。
在一项为期 5 年的重复横断面集群随机试验中,桑给巴尔岛的 90 个(小行政区域;集群)由于存在天然开放的淡水水体和公立小学而符合条件,被随机分配(比例 1:1:1)接受三种干预措施之一:每两年单独使用吡喹酮进行 MDA(第 1 组)或与灭螺联合使用(第 2 组),或进行行为改变活动(第 3 组)。参与者、现场或实验室人员均未对干预组进行盲法处理。从 2012 年至 2017 年,每年从每个 shehia 的主要公立小学收集约 100 名 9-12 岁儿童的单次尿液样本。主要结局是 5 年随访后 9-12 岁儿童的血吸虫病感染率和感染强度。该研究已经完成,并在 ISRCTN 注册,编号为 48837681。
试验于 2011 年 11 月 1 日至 2017 年 12 月 31 日进行,招募工作于 2011 年 11 月 2 日至 2017 年 5 月 17 日进行。基线时我们招募了 8278 名参与者,其中 2899 名(35%)被随机分配到第 1 组,2741 名(33%)分到第 2 组,2638 名(32%)分到第 3 组。第 1 组有 2853 名中的 120 名(4.2%)、第 2 组有 2688 名中的 209 名(7.8%)和第 3 组有 2613 名中的 167 名(6.4%)在基线时患有血吸虫病。在基线时,126 名(1.6%)8073 名儿童中有重度感染(≥50 条虫卵/10 毫升尿液)。在 5 年的终线调查中,第 1 组有 46 名(1.4%)3184 名、第 2 组有 56 名(1.7%)3217 名(比值比 [OR] 1.2 [95%CI 0.6-2.7]与第 1 组相比)和第 3 组有 58 名(1.9%)3080 名(1.3 [0.6-2.9])患有血吸虫病。在 9462 名儿童中发现 33 名(0.3%)患有重度感染。
每两年进行一次 MDA 可显著降低血吸虫病的流行率和感染强度,但不足以阻断传播。虽然在我们的研究中,灭螺或行为改变活动并没有显著增强 MDA 的效果,但当针对局部流行区并延长应用时间时,它们可能会增强传播的阻断。现在有必要专注于降低剩余热点地区的流行率,并引入新的监测和公共卫生应对方法,以保持和推进已取得的重要成果。
佐治亚大学研究基金会和比尔和梅琳达·盖茨基金会。